Two companies report Rs 500 crore in EBITDA. Both are profitable. Both are growing. Both have clean audits, positive cash flow and manageable debt.
An investor offers Company A a valuation of 12x EBITDA: Rs 6,000 crore. Company B receives 8x: Rs 4,000 crore.
The Rs 2,000 crore difference is not explained by earnings. It is not explained by growth. It is not explained by sector or geography. It is explained by what would happen to the EBITDA if specific dependencies were removed.
Company A has diversified revenue across 300 customers, none exceeding 3%. Its supplier base spans four geographies. Its management team operates independently of the founder. Its key relationships are institutional, embedded in systems and processes rather than individuals. Its revenue is distributed across product lines, regions and channels.
Company B generates 40% of its revenue from five customers. One promoter personally controls the three largest client relationships. 60% of revenue originates from a single geography. The primary raw material comes from two suppliers, both in the same country. Three individuals hold the institutional knowledge required to run operations. No succession plan exists.
Same EBITDA. Same sector. Same year. Rs 2,000 crore difference in what a rational buyer would pay.
That difference is the concentration discount. And it is the single most undervalued variable in Indian mid-market corporate finance.
What the Concentration Discount Measures
The concentration discount is the reduction in enterprise value attributable to the fragility of the earnings base. It answers a question that conventional financial analysis avoids: not how much does the company earn, but how much of what it earns would survive if specific dependencies were disrupted?
EBITDA is a measure of current earnings power. It tells you what the business produced this year, under this year's conditions, with this year's customers, suppliers, people and operating environment intact. It says nothing about how durable those conditions are.
A buyer, lender or investor pricing the business for the next decade needs to know something the EBITDA figure cannot tell them: what portion of this earnings power is structurally resilient, and what portion is contingent on dependencies the company does not control?
The concentration discount is the market's answer to that question. And it operates across seven dimensions simultaneously.
The Seven Dimensions of Concentration
1. Customer concentration
The most commonly recognised form of dependency and still the most commonly underestimated. A company where the top five customers generate 50% of revenue does not carry 50% risk. It carries more than 50% risk, because the loss of a major customer does not reduce revenue proportionally. It triggers a cascade: underutilised capacity, stranded fixed costs, demoralised sales teams, nervous lenders and supplier uncertainty.
The concentration discount for customer dependency is not linear. The first 10% of concentration carries modest risk. The next 20% carries disproportionate risk. Beyond 40% concentration in five customers, the earnings base becomes structurally fragile in a way that sophisticated buyers, PE firms and lenders will price aggressively.
The forensic question: What is the company's revenue net of its top three customers, and is that residual revenue growing or shrinking?
2. Supplier concentration
A company sourcing 70% of a critical input from a single supplier has not optimised its procurement. It has created an invisible liability.
The supplier controls pricing, delivery timing, quality consistency and, ultimately, the company's ability to fulfil its own customer commitments. A supply disruption, whether from the supplier's financial distress, a geopolitical event, a regulatory change or a logistics failure, does not reduce the company's input by 70%. It halts production entirely if no qualified alternative exists.
In our due diligence work, Northrop Management Private Limited routinely finds that supplier concentration is the dependency dimension companies are least aware of. Procurement teams optimise for cost. They rarely model the enterprise value at risk from their sourcing architecture.
The forensic question: If the primary supplier of each critical input became unavailable for 90 days, what happens to revenue, margins and customer commitments?
3. Promoter and founder concentration
In Indian mid-market companies, this is frequently the largest invisible liability on the invisible balance sheet.
A promoter who personally holds the top customer relationships, makes all capital allocation decisions, controls the banking relationships, and is the sole point of contact for regulatory interactions has not built a business. They have built a practice with corporate infrastructure. The enterprise value of the business is substantially the enterprise value of the promoter's continued involvement.
An acquirer evaluating this company must answer: what is the EBITDA worth after the promoter's three-year earn-out period ends and they step back? If the answer is materially lower than current EBITDA, the concentration discount should be applied to the purchase price, and it frequently is.
The forensic question: What percentage of the company's revenue, relationships and decision-making capability would survive an unplanned 12-month absence of the founder?
4. Key-person dependency
Distinct from promoter concentration, this captures the risk embedded in specific non-founder individuals whose knowledge, relationships or capabilities are critical and unreplicated.
The head of manufacturing who is the only person who understands how the production line actually runs. The CFO who personally manages the relationship with the company's primary lender. The sales director whose personal network generates 30% of new business. The compliance officer who is the sole custodian of the company's regulatory history and relationships.
Each of these individuals represents a concentration of institutional capability in a single point of failure. The company's visible balance sheet records their salary as an expense. The invisible balance sheet should record their departure as a contingent liability.
The forensic question: Name the five individuals whose simultaneous departure would cause the most damage. Now ask: is any of their knowledge, any of their relationships, any of their capability documented, transferred or replicated?
5. Geographic concentration
A company generating 60% of revenue from a single state, a single city, or a single country carries geographic concentration risk that directly affects enterprise value.
Geographic concentration exposes the company to localised economic downturns, regulatory changes, natural disasters, political instability and competitive dynamics that a diversified company can absorb. A retail chain with 80% of its stores in one state is not simply concentrated geographically. It is concentrated across every variable that correlates with geography: customer demographics, regulatory environment, labour market, supply chain logistics and competitive landscape.
The forensic question: What is the company's revenue and margin profile excluding its single largest geography, and does the remainder constitute a viable business?
6. Product concentration
A company generating 70% of revenue from a single product line or service category carries concentration risk that is often masked by overall growth.
The product may be in a strong market position today. But product concentration means that a shift in customer preference, a technological disruption, a regulatory change affecting that specific product, or a competitor's aggressive pricing move does not reduce one revenue stream. It threatens the company's economic viability.
The forensic question: If demand for the company's primary product declined by 30% over 18 months, does the remaining business generate sufficient cash flow to service its fixed cost base and debt obligations?
7. Lender concentration
A company whose entire debt is with a single bank or a small group of lenders carries a dependency that becomes visible only under stress.
When the company is performing well, single-lender relationships are efficient: faster decisions, lower documentation burden, established relationships. When the company faces a downturn, a covenant breach or a refinancing need, single-lender concentration becomes a structural vulnerability. The lender's internal credit appetite, portfolio limits, sector exposure policies and personnel changes can all affect the company's access to capital in ways that a diversified lending base would mitigate.
The forensic question: If the company's primary lender declined to renew its facilities at maturity, how quickly and at what cost could the company replace that capacity?
The Valuation Arithmetic: How Concentration Becomes a Discount
The mechanics of the concentration discount are straightforward, even when the precise calibration is judgment-dependent.
Step 1: Identify the stated EBITDA.
The company reports Rs 500 crore.
Step 2: Identify the defensible EBITDA.
This is the EBITDA that would survive the loss of the company's single largest dependency in each dimension. Not all dependencies simultaneously, which would be a catastrophic scenario, but each one independently.
What is EBITDA if the largest customer is lost? If the primary supplier is disrupted for a quarter? If the promoter steps back? If the key geography faces a downturn? If the primary product faces a demand shift?
The defensible EBITDA is the floor below which the company's earnings would stabilise after absorbing its most probable single-dependency shock. For a highly concentrated company, this might be Rs 300 crore. For a diversified one, it might be Rs 450 crore.
Step 3: Apply the multiple to the defensible EBITDA, not the stated EBITDA.
A sophisticated buyer does this implicitly. They may nominally offer 10x on Rs 500 crore (Rs 5,000 crore), but they arrived at that number by applying 12x to the Rs 420 crore they believe is defensible. The concentration discount is embedded in the multiple, whether the seller recognises it or not.
Step 4: Quantify the concentration discount.
Concentration Discount = (Stated EBITDA - Defensible EBITDA) × Multiple
For a company with Rs 500 crore stated EBITDA, Rs 350 crore defensible EBITDA and a sector multiple of 12x, the concentration discount is Rs 1,800 crore. That is the enterprise value the company has forfeited by failing to diversify its dependencies.
This is not a theoretical calculation. It is the calculation that every PE firm, strategic acquirer and sophisticated lender performs, whether or not they share it with the seller.
Why Indian Mid-Market Companies Are Especially Exposed
The concentration discount affects mid-market companies disproportionately for structural reasons.
Promoter-led growth creates natural concentration. In the early stages, the promoter personally wins the first customers, builds the first supplier relationships, and manages the first banking facility. This concentration is efficient during the startup phase. It becomes a valuation liability when the company scales but the dependencies do not diversify.
Relationship-driven commerce favours concentration. Indian business culture prizes personal relationships in commercial transactions. A promoter who has cultivated a deep relationship with five major customers will resist diversification because the relationships work. The concentration discount is the price the company pays for that comfort at the point of transaction or capital raise.
Growth masks fragility. A company growing at 25% per year with 50% customer concentration does not feel fragile. The revenue is increasing. The customers are paying. The margins are expanding. The concentration risk is invisible until it crystallises, at which point the growth narrative reverses and the valuation discount arrives in a single quarter.
Ashish Chaudhary, frames the valuation reality directly: "The market does not pay for EBITDA. It pays for the durability of EBITDA. A company that earns Rs 500 crore from a fragile structure and a company that earns Rs 500 crore from a resilient structure are not the same asset. They should not receive the same price. And in practice, they do not."
The Northrop Perspective
In Northrop Management forensic reviews and due diligence engagements, the concentration discount is one of the first analytical exercises we perform.
The question is not what the company earns. It is what the company would earn if each of its major dependencies were independently stressed. The gap between stated and defensible earnings is the concentration discount, and it directly informs our assessment of enterprise value, credit risk and governance quality.
This analysis connects directly to the Northrop Business Operability Index (NBOI), which scores how operable a business remains under stress. A company with high concentration across multiple dimensions, customer, supplier, founder, geography, product, will score poorly on operability precisely because its earnings power is contingent on conditions it does not fully control.
The companies that invest in diversification before they need to, before a transaction, before a downturn, before a key dependency fails, are the ones that preserve enterprise value. The ones that discover their concentration discount during a buyer's due diligence are the ones that negotiate from weakness.
What Boards and Promoters Should Do Now
Map concentration across all seven dimensions. Customer, supplier, promoter, key person, geography, product and lender. For each, identify the single largest dependency and quantify the revenue, margin or operational impact of its loss.
Calculate the defensible EBITDA. Model the company's earnings under a single-dependency stress scenario for each dimension. The lowest figure across all seven scenarios is the company's defensible earnings floor. The gap between that floor and stated EBITDA is the concentration discount the market will apply.
Build a diversification roadmap. For each concentration above a defined threshold (20% for customers, 50% for suppliers, any single-person dependency for key roles), develop a specific, time-bound plan to reduce the dependency. This is not a strategic exercise. It is a valuation exercise. Every percentage point of concentration reduced translates directly into enterprise value preserved.
Institutionalise relationships. The most actionable form of diversification for promoter-led businesses is transferring relationships from individuals to institutions. A customer relationship held by the promoter is a personal asset. A customer relationship managed through a structured key account programme, with documented history, multiple touchpoints and institutional continuity, is a corporate asset. The first reduces enterprise value at exit. The second preserves it.
Disclose concentration proactively. In any capital raise, transaction or lending discussion, disclosing concentration risk alongside a credible diversification plan creates more value than attempting to obscure it. Sophisticated counterparties will find it. Companies that surface it first, with a plan, negotiate from strength.
Questions for the Boardroom
- What is our defensible EBITDA after removing our single largest customer, and how does that compare to the EBITDA we present to investors and lenders?
- Which of our seven concentration dimensions carries the largest valuation discount, and what would it cost to reduce it by half?
- How many of our top ten customer relationships would survive a change in the individual who currently manages them?
- If a buyer applied a concentration discount to our valuation today, how much enterprise value would we lose, and is that amount larger than the cost of diversification?
- Are we building a company that is valuable because of what it earns, or a company that is valuable because of how durably it earns it?
Closing Implication
The market does not pay for EBITDA. It pays for the structural durability of EBITDA.
A company that earns Rs 500 crore from a diversified, institutionalised, resilient operating structure and a company that earns Rs 500 crore from a concentrated, promoter-dependent, geographically narrow structure may report the same profit. They do not carry the same enterprise value. They do not carry the same credit risk. They do not carry the same capacity to survive the next disruption.
The concentration discount is the price the market charges for fragility. It is applied silently, embedded in the multiple, and discovered by the seller only when the buyer's offer arrives below expectation.
The companies that understand this before the transaction, before the capital raise, before the credit review, are the ones that convert concentration into diversification while the cost of doing so is low and the time to do it is available.
The ones that do not will learn the price of their dependencies at the exact moment when the price is highest and the ability to change is lowest.
